|
|
 |
|
Viewing report
|
|
|
|
Global Generic Injectables Market 2009-15
Avalon Global Research, Oct 2010, Pages: 20
As majority of the blockbuster drugs are set to go off patent in the next few years, $140 bn injectables market is set to assume prominence as the fastest growing and the most preferred drug delivery mode in place of oral formulations. Relatively high insulation from competition post off- patent stage, strong entry barriers, high profit margin and drug effectiveness are making injectables more popular than oral formulations.
We have employed a combination of secondary research and in depth interviews with key players to validate our findings and further understand the underlying trends and strategies. Extensive triangulation has been done to categorize and estimate the injectables market data.
In this report, we have focused on the bright prospects of $17.5 bn generic injectables sub segment which is expected to witness a compounded annual growth of 15% over the next five years. We expect a market opportunity of USD 1.6 bn to open up for the generic injectables in the regulated markets following the drugs going off patent. Further, we see a strong business case for collaboration of global and regional players in the injectables segment to expand the market. The market estimates and breakdown have also been provided for the injectables segment by product, therapeutic and geographic basis.
The mergers and acquisitions are gathering pace and we expect more such to happen in the coming days. Given that the hospitals prefer injectables for oncology treatment instead of oral formulations and also the fact the injectables segment are not crowded has fuelled a rush for acquisitions. Oncology accounts for a large portion of both biological and non biological injectables globally.
In this report we have identified and profiled some of the leading players in the injectables segment. In this report, we have put special emphasis on estimating the hitherto unexplored niche respiratory and ophthalmological injectables segment. This reports attempts to provide a macro view of the generic injectables market and not an in depth review of all sub segments.
The report will provide to be a useful guide for pharma majors, bio pharma and biotechnology companies, researchers, academicians, financial community and all those associated with drug research and marketing. We believe that this report will help all the stakeholders associated with the pharma industry to spot the business opportunities post expiry of major drug patents.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Global Biopharma Outlook 2011
Successful Strategies for Pharmaceutical Reformulation
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
Pharmaceuticals - Global Outlook
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets
Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators
Patent Expiry Strategies of Big Pharma
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
|
|
|
|
